Cargando…
Antiviral Activity against SARS-CoV-2 of Conformationally Constrained Helical Peptides Derived from Angiotensin-Converting Enzyme 2
[Image: see text] Despite the availability of vaccines, COVID-19 continues to be aggressive, especially in immunocompromised individuals. Therefore, the development of a specific therapeutic agent with antiviral activity against SARS-CoV-2 is necessary. The infection pathway starts when the receptor...
Autores principales: | Quagliata, Michael, Stincarelli, Maria Alfreda, Papini, Anna Maria, Giannecchini, Simone, Rovero, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275481/ https://www.ncbi.nlm.nih.gov/pubmed/37387789 http://dx.doi.org/10.1021/acsomega.3c01436 |
Ejemplares similares
-
SARS-CoV-2 inhibitory activity of a short peptide derived from internal fusion peptide of S2 subunit of spike glycoprotein
por: Stincarelli, Maria Alfreda, et al.
Publicado: (2023) -
Antiviral Activity of Oligonucleotides Targeting the SARS-CoV-2 Genomic RNA Stem-Loop Sequences within the 3′-End of the ORF1b
por: Stincarelli, Maria Alfreda, et al.
Publicado: (2022) -
Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013) -
Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020) -
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)